What development phase is LUFENURON in?

LUFENURON is FDA-approved (marketed).

What are the side effects of LUFENURON?

Common side effects include Vomiting, Depression/Lethargy, Pruritus, Urticaria, Diarrhea, Anorexia.

Last reviewed 2026-04-20 · How we verify

LUFENURON

FDA-approved active Small molecule Quality 6/100

Lufenuron is a marketed drug that inhibits chitin synthesis in insects and other arthropods, positioning it as a unique solution in pest control. Its key strength lies in its distinct mechanism of action, which differentiates it from other pest control agents. The primary risk is the expiration of the key composition patent in 2028, which could lead to increased competition from generics.

At a glance

Generic name	LUFENURON
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

Vomiting
Depression/Lethargy
Pruritus
Urticaria
Diarrhea
Anorexia
Skin Congestion
Ataxia
Convulsions
Salivation
Weakness